T3-21  Hsp90β inhibitors prevent GLT- 1 degradation but have no beneficial efficacy on absence epilepsy

PENG Yu- chen, WANG Shan, ZHANG Yong, HUANG Long-jian, ZHOU Yu-jun, WANG Xiao-liang, PENG Ying

PDF(596 KB)
中国药理学与毒理学杂志
PDF(596 KB)
中国药理学与毒理学杂志 ›› 2018, Vol. 32 ›› Issue (9) : 724-724.
专题3：药物成瘾与精神疾病

T3-21  Hsp90β inhibitors prevent GLT- 1 degradation but have no beneficial efficacy on absence epilepsy

    {{javascript:window.custom_author_cn_index=0;}}
  • {{article.zuoZhe_CN}}
作者信息 +

T3-21  Hsp90β inhibitors prevent GLT- 1 degradation but have no beneficial efficacy on absence epilepsy

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

本文亮点

{{article.keyPoints_cn}}

HeighLight

{{article.keyPoints_en}}

摘要

{{article.zhaiyao_cn}}

Abstract

{{article.zhaiyao_en}}

关键词

Key words

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用
{{article.zuoZheCn_L}}. {{article.title_cn}}. {{journal.qiKanMingCheng_CN}}. 2018, 32(9): 724-724
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2018, 32(9): 724-724

参考文献

原文顺序 | 文献年度倒序 | 文中引用次数倒序

参考文献

{{article.reference}}

基金

版权

{{article.copyrightStatement_cn}}
{{article.copyrightLicense_cn}}
PDF(596 KB)

Accesses

Citation

Detail
段落导航
相关文章

/

〈 〉